(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-CD40 PARA USO NA PREVENÇÃO DE REJEIÇÃO DE ENXERTO

ArquivadaInvention PatentPCT · IB2019052976

Application data

Number

112020020277

Type

Invention Patent

Filing

04/11/2019

Publication

01/19/2021

PCT

IB2019052976

Progress at the INPI

  1. Filing04/11/19
  2. Publication01/19/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 04/11/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/04/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

NOVARTIS AG

CH

See this company's full portfolio

Inventors

B. H. (pessoa física)

CH

J. R. (pessoa física)

CH

P. E. (pessoa física)

CH

Technical data

Priority claims

EA

18208332.9 · 11/26/2018

US

62/657,172 · 04/13/2018

Abstract

ANTICORPOS ANTI-CD40 PARA USO NA PREVENÇÃO DE REJEIÇÃO. A presente invenção refere-se a métodos, regimes de tratamento, usos, kits e terapias para prevenir a rejeição de enxertos em transplantes de órgãos sólidos, empregando-se anticorpos anti-CD40.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

10/04/2022

RPI 2700

Arquivamento - Art. 33 da LPI

#11.1

07/19/2022

RPI 2689

Adição na publicação

#15.35

12/14/2021

RPI 2658

Notificação de entrada na fase nacional - PCT

#1.3

01/19/2021

RPI 2611

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.